Fox Run Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $304K | Sell |
35,861
-9,101
| -20% | -$77.1K | 0.05% | 633 |
|
|
2025
Q1 | $361K | Buy |
44,962
+24,777
| +123% | +$199K | 0.06% | 616 |
|
|
2024
Q4 | $181K | Buy |
+20,185
| New | +$181K | 0.03% | 763 |
|
|
2024
Q3 | – | Sell |
-28,797
| Closed | -$164K | – | 795 |
|
|
2024
Q2 | $164K | Buy |
28,797
+1,545
| +6% | +$8.82K | 0.03% | 694 |
|
|
2024
Q1 | $137K | Buy |
+27,252
| New | +$137K | 0.03% | 685 |
|
|
2023
Q4 | – | Sell |
-15,391
| Closed | -$120K | – | 726 |
|
|
2023
Q3 | $120K | Sell |
15,391
-38,436
| -71% | -$299K | 0.04% | 610 |
|
|
2023
Q2 | $521K | Buy |
+53,827
| New | +$521K | 0.15% | 274 |
|
|
2023
Q1 | – | Sell |
-34,281
| Closed | -$148K | – | 650 |
|
|
2022
Q4 | $148K | Buy |
34,281
+6,788
| +25% | +$29.3K | 0.06% | 526 |
|
|
2022
Q3 | $207K | Buy |
+27,493
| New | +$207K | 0.08% | 470 |
|